Approximately 141,000 patients will develop colorectal cancer each year and 45% will have positive lymph nodes, one of the most significant predictors of survival. Now there is evidence that systemic chemotherapy with fluorouracil (FU) and leucovorin, levamisole, or FU and leucovorin with decrease recurrence and increase survival for patients with Dukes' C colon cancer. In patients with Dukes' B or C rectal cancer, combined radiation and FU increase survival and decrease local and distal recurrence.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
colorectal cancer
8
increase survival
8
patients dukes'
8
adjuvant therapy
4
therapy colorectal
4
cancer
4
cancer 141000
4
141000 patients
4
patients will
4
will develop
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!